Multiple studies have show the drug is not effective at treating COVID-19, and in some cases can even cause heart problems.
The test is intended for large-scale testing of patients, with the capacity to test 180,000 samples over the next 90 days.
Desperate times call for desperate measures.
The prospect that hydroxychloroquine might be effective for treating the coronavirus has raised hopes, but it’s also created a potential crisis.
Typically, a promising new experimental drug arrives on the scene with a flourish. But sometimes, it’s a long and winding road.
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.